PVI
FBRX icon

Pura Vida Investments’s Forte Biosciences FBRX Stock Holding History

Pura Vida Investments’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,623
Closed -$2.21M – 296
2021
Q2 		$2.21M Sell
2,623
-1,916
-42% -$1.73M 0.07% 152
2021
Q1 		$3.89M Buy
4,539
+1,939
+75% +$1.59M 0.11% 132
2020
Q4 		$2.37M Buy
+2,600
New +$2.44M 0.09% 139

Other funds holding FBRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
OQS
Occudo Quantitative Strategies Fort Lauderdale, Florida $1.84B AUM 22.15% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Pura Vida Investments's FBRX Position: Q3 2021 in Review

Pura Vida Investments sold out of Forte Biosciences (FBRX) in Q3 2021, closing a stake of 2,623 shares — an estimated $2.21M sold.

Pura Vida Investments first reported a position in FBRX in Q4 2020 and held it in 3 quarters. The position peaked at $3.89M in Q1 2021. 57 funds tracked by Wall St. Rank hold FBRX as of Q3 2021.

  • Pura Vida Investments reported no remaining Forte Biosciences position as of Q3 2021 after selling out during the quarter.
  • Pura Vida Investments sold 2,623 Forte Biosciences shares in Q3 2021, an estimated $2.21M.
  • Pura Vida Investments first reported a position in Forte Biosciences in Q4 2020 and held it in 3 quarters.
  • Pura Vida Investments's Forte Biosciences position peaked at $3.89M in Q1 2021.
  • 57 funds tracked by Wall St. Rank held Forte Biosciences as of Q3 2021.

Based on Pura Vida Investments's 13F filing for Q3 2021, filed 15 Nov 2021.